SA
BSX icon

Scarborough Advisors’s Boston Scientific BSX Stock Holding History

Scarborough Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-280
Closed -$17.6K – 218
2026
Q1 		$17.6K Buy
+280
New +$22.4K ﹤0.01% 367
2024
Q1 		– Sell
-115
Closed -$6.65K – 428
2023
Q4 		$6.65K Buy
+115
New +$6.14K ﹤0.01% 436

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Scarborough Advisors's BSX Position: Q2 2026 in Review

Scarborough Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 280 shares — an estimated $17.6K sold.

Scarborough Advisors first reported a position in BSX in Q4 2023 and held it in 2 quarters. The position peaked at $17.6K in Q1 2026. 257 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Scarborough Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 280 Boston Scientific shares in Q2 2026, an estimated $17.6K.
  • Scarborough Advisors first reported a position in Boston Scientific in Q4 2023 and held it in 2 quarters.
  • Scarborough Advisors's Boston Scientific position peaked at $17.6K in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.